You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Flt3 ligand protein

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

Completed
Has Results
  • Cutaneous Melanoma
  • +11 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +2 more
  • Chicago, Illinois
  • +6 more
Nov 10, 2021

Non Small Cell Lung Cancer, Lung Cancer Trial in Bronx (drug, biological, radiation)

Recruiting
  • Non Small Cell Lung Cancer
  • Lung Cancer
  • FLT3 Ligand (CDX-301)
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Jul 18, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

NSCLC (NSCLC) Trial in Bronx (FLT3 Ligand Therapy (CDX-301), Stereotactic Body Radiotherapy (SBRT))

Active, not recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • FLT3 Ligand Therapy (CDX-301)
  • Stereotactic Body Radiotherapy (SBRT)
  • Bronx, New York
    Montefiore Medical Center
Nov 5, 2021

Metastatic Triple Negative Breast Cancer Trial in Dallas (PLD Chemotherapy, CDX-1140, CDX-301)

Recruiting
  • Metastatic Triple Negative Breast Cancer
  • PLD Chemotherapy
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jun 23, 2022

Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in New York (Pembrolizumab, Flt3L,

Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 18, 2021

Advanced Solid Tumors Trial in United States (GS-3583)

Active, not recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +3 more
Jul 22, 2022

New Cytokine-based Dynamic Stratification Based on FLt3 Ligand

Recruiting
  • Acute Myeloid Leukemia
  • No intervention
  • Strasbourg, Bas-Rhin, France
  • +24 more
Aug 25, 2021

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia Trial in Columbus (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 4, 2022

Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
  • +15 more
Jan 13, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

Melanoma Trial (biological, drug, radiation)

Withdrawn
  • Melanoma
  • Avelumab
  • +17 more
  • (no location specified)
Mar 17, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)

Suspended
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Adelaide, Australia
  • +193 more
Jan 5, 2023

Urothelial Carcinoma Trial (biological, drug, radiation)

Withdrawn
  • Urothelial Carcinoma
  • avelumab
  • +19 more
  • (no location specified)
Mar 17, 2021

NSCLC Trial in Worldwide (Sacituzumab Govitecan-hziy (SG), Docetaxel)

Recruiting
  • Non-Small Cell Lung Cancer
  • Anchorage, Alaska
  • +104 more
Jul 20, 2022

NSCLC Trial (biological, drug, radiation)

Withdrawn
  • Non-small Cell Lung Cancer
  • avelumab
  • +21 more
  • (no location specified)
Mar 17, 2021

Breast Cancer Trial in United States (radiation, drug, biological)

Recruiting
  • Breast Cancer
  • Focal Radiation therapy
  • +2 more
  • Los Angeles, California
  • +6 more
Apr 29, 2022

Head and Neck Squamous Cell Carcinoma Trial (biological, drug, radiation)

Withdrawn
  • Head and Neck Squamous Cell Carcinoma
  • Avelumab
  • +21 more
  • (no location specified)
Mar 17, 2021

Cancer (With or Without Metastasis) Trial in Houston (TSN084)

Recruiting
  • Cancer (With or Without Metastasis)
  • Houston, Texas
    MD Anderson Cancer Center
Apr 22, 2022

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

The Gut Microbiome and Immunotherapy Response in Solid Cancers

Recruiting
  • Cancer
    • Galveston, Texas
      University of Texas Medical Branch
    Sep 15, 2023

    Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)

    Recruiting
    • Urothelial Cancer
    • Niraparib plus Cabozantinib
    • Barcelona, Cataluña, Spain
    • +10 more
    Feb 8, 2022

    Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
    • Los Angeles, California
    • +110 more
    Jan 26, 2023